Abstract P5-01-05: Genomic alterations detected by circulating tumor DNA and correlation with response to treatment with elacestrant, an oral selective estrogen receptor degrader, in phase 1 trials in postmenopausal women with ER+/HER2- advanced/metastatic breast cancer
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Teeru Bihani, JungAh Jung, Hitisha K Patel, Aditya Bardia, Peter Kabos, Virginia Kaklamani, Agnes Jager, Philippe Aftimos, Sharon Wilks, Elisabeth de Vries, Wael Harb, Donald Richards, Amy Weise, Robert Wesolowski, Catharina CW Menke-van der Houven van Oordt, Paul Conkling, Patrick Neven, Maureen G Conlan
Institutions: Radius Health (United States), Massachusetts General Hospital, The University of Texas Health Science Center at Houston, Erasmus MC, Université Libre de Bruxelles, Institut Jules Bordet, University Medical Center Groningen, Horizon Oncology Center, The Barbara Ann Karmanos Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Amsterdam University Medical Centers, Virginia Oncology Associates, Universitair Ziekenhuis Leuven
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3013013722